Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye.
Turk J Haematol. 2023 Dec 5;40(4):242-250. doi: 10.4274/tjh.galenos.2023.2023.0029. Epub 2023 Nov 14.
Turk J Haematol. 2023.
PMID: 37961952
Free PMC article.
Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data.
Aslaner Ak M, Gedük A, Acar İH, Polat MG, Sunu C, Bolaman AZ, Hacıbekiroğlu T, Güvenç B, Ertop Ş.
Aslaner Ak M, et al.
Turk J Haematol. 2023 May 29;40(2):92-100. doi: 10.4274/tjh.galenos.2023.2022.0437. Epub 2023 Feb 17.
Turk J Haematol. 2023.
PMID: 36799095
Free PMC article.
Item in Clipboard
Multiple muscle involvement in relapsed multiple myeloma: A rare case.
Aslaner Ak M, Erdemir RU.
Aslaner Ak M, et al.
J Cancer Res Ther. 2022 Jul-Sep;18(4):1165-1167. doi: 10.4103/jcrt.jcrt_156_22.
J Cancer Res Ther. 2022.
PMID: 36149178
Free article.
Item in Clipboard
Tyrosine kinase inhibitor nilotinib induced palmoplantar erythrodysesthesia: A rare case.
Aslaner Ak M, Ertop Doğan P, Sahip B.
Aslaner Ak M, et al.
J Oncol Pharm Pract. 2022 Apr;28(3):763-765. doi: 10.1177/10781552211072465. Epub 2022 Jan 4.
J Oncol Pharm Pract. 2022.
PMID: 35465793
Review.
Item in Clipboard
Cite
Cite